A specialty pharmaceutical manufacturer focused on developing, producing, and marketing generic and branded medications, with particular strength in complex generics and central nervous system therapies. The company operated both a generic drug portfolio and a smaller branded segment targeting neuro...
1 member of Congress has disclosed 1 trade in Impax Laboratories, Inc. (IPXL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-31 | Josh Gottheimer | buy | $1K – $15K |